Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Urinary Tract Infections
1.2.3 Surgical Site Infections
1.2.4 Hospital-acquired Pneumonia
1.2.5 BloodStream Infections
1.2.6 Gastrointestinal Infections
1.3 Market by Application
1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 ASCs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2018-2033)
2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Region
2.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Healthcare-associated Infectious Disease Diagnostics Market Dynamics
2.3.1 Healthcare-associated Infectious Disease Diagnostics Industry Trends
2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue
3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2022
3.5 Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2033)
5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2018-2033)
6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2018-2023)
6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2018-2033)
7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2018-2023)
7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2018-2033)
9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Detail
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.2.5 Accelerate Diagnostics Recent Development
11.3 BD
11.3.1 BD Company Detail
11.3.2 BD Business Overview
11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.3.5 BD Recent Development
11.4 bioMrieux
11.4.1 bioMrieux Company Detail
11.4.2 bioMrieux Business Overview
11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.4.5 bioMrieux Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Detail
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.5.5 Bio-Rad Recent Development
11.6 DiaSorin Molecular
11.6.1 DiaSorin Molecular Company Detail
11.6.2 DiaSorin Molecular Business Overview
11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.6.5 DiaSorin Molecular Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Detail
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Luminex
11.8.1 Luminex Company Detail
11.8.2 Luminex Business Overview
11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.8.5 Luminex Recent Development
11.9 Meridian Bioscience
11.9.1 Meridian Bioscience Company Detail
11.9.2 Meridian Bioscience Business Overview
11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.9.5 Meridian Bioscience Recent Development
11.10 OpGen
11.10.1 OpGen Company Detail
11.10.2 OpGen Business Overview
11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.10.5 OpGen Recent Development
11.11 QIAGEN
11.11.1 QIAGEN Company Detail
11.11.2 QIAGEN Business Overview
11.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
11.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.11.5 QIAGEN Recent Development
11.12 Quidel
11.12.1 Quidel Company Detail
11.12.2 Quidel Business Overview
11.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
11.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.12.5 Quidel Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Detail
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
11.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 Trinity Biotech
11.14.1 Trinity Biotech Company Detail
11.14.2 Trinity Biotech Business Overview
11.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
11.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.14.5 Trinity Biotech Recent Development
11.15 Danaher
11.15.1 Danaher Company Detail
11.15.2 Danaher Business Overview
11.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
11.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
11.15.5 Danaher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Urinary Tract Infections
Table 3. Key Players of Surgical Site Infections
Table 4. Key Players of Hospital-acquired Pneumonia
Table 5. Key Players of BloodStream Infections
Table 6. Key Players of Gastrointestinal Infections
Table 7. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2018-2023)
Table 11. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2024-2033)
Table 13. Healthcare-associated Infectious Disease Diagnostics Market Trends
Table 14. Healthcare-associated Infectious Disease Diagnostics Market Drivers
Table 15. Healthcare-associated Infectious Disease Diagnostics Market Challenges
Table 16. Healthcare-associated Infectious Disease Diagnostics Market Restraints
Table 17. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players (2018-2023)
Table 19. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2022)
Table 20. Ranking of Global Top Healthcare-associated Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
Table 24. Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2018-2023)
Table 28. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2024-2033)
Table 30. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2018-2023)
Table 32. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2024-2033)
Table 34. North America Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 49. Abbott Company Detail
Table 50. Abbott Business Overview
Table 51. Abbott Healthcare-associated Infectious Disease Diagnostics Product
Table 52. Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 53. Abbott Recent Development
Table 54. Accelerate Diagnostics Company Detail
Table 55. Accelerate Diagnostics Business Overview
Table 56. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product
Table 57. Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 58. Accelerate Diagnostics Recent Development
Table 59. BD Company Detail
Table 60. BD Business Overview
Table 61. BD Healthcare-associated Infectious Disease Diagnostics Product
Table 62. BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 63. BD Recent Development
Table 64. bioMrieux Company Detail
Table 65. bioMrieux Business Overview
Table 66. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product
Table 67. bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 68. bioMrieux Recent Development
Table 69. Bio-Rad Company Detail
Table 70. Bio-Rad Business Overview
Table 71. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product
Table 72. Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 73. Bio-Rad Recent Development
Table 74. DiaSorin Molecular Company Detail
Table 75. DiaSorin Molecular Business Overview
Table 76. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product
Table 77. DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 78. DiaSorin Molecular Recent Development
Table 79. F. Hoffmann-La Roche Company Detail
Table 80. F. Hoffmann-La Roche Business Overview
Table 81. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product
Table 82. F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 83. F. Hoffmann-La Roche Recent Development
Table 84. Luminex Company Detail
Table 85. Luminex Business Overview
Table 86. Luminex Healthcare-associated Infectious Disease Diagnostics Product
Table 87. Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 88. Luminex Recent Development
Table 89. Meridian Bioscience Company Detail
Table 90. Meridian Bioscience Business Overview
Table 91. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product
Table 92. Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 93. Meridian Bioscience Recent Development
Table 94. OpGen Company Detail
Table 95. OpGen Business Overview
Table 96. OpGen Healthcare-associated Infectious Disease Diagnostics Product
Table 97. OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 98. OpGen Recent Development
Table 99. QIAGEN Company Detail
Table 100. QIAGEN Business Overview
Table 101. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product
Table 102. QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 103. QIAGEN Recent Development
Table 104. Quidel Company Detail
Table 105. Quidel Business Overview
Table 106. Quidel Healthcare-associated Infectious Disease Diagnostics Product
Table 107. Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 108. Quidel Recent Development
Table 109. Thermo Fisher Scientific Company Detail
Table 110. Thermo Fisher Scientific Business Overview
Table 111. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product
Table 112. Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 113. Thermo Fisher Scientific Recent Development
Table 114. Trinity Biotech Company Detail
Table 115. Trinity Biotech Business Overview
Table 116. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product
Table 117. Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 118. Trinity Biotech Recent Development
Table 119. Danaher Company Detail
Table 120. Danaher Business Overview
Table 121. Danaher Healthcare-associated Infectious Disease Diagnostics Product
Table 122. Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 123. Danaher Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Urinary Tract Infections Features
Figure 4. Surgical Site Infections Features
Figure 5. Hospital-acquired Pneumonia Features
Figure 6. BloodStream Infections Features
Figure 7. Gastrointestinal Infections Features
Figure 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. ASCs Case Studies
Figure 13. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region: 2022 VS 2033
Figure 17. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players in 2022
Figure 18. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2022
Figure 20. North America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 22. United States Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 26. Germany Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2018-2033)
Figure 34. China Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 42. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 46. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 49. Accelerate Diagnostics Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 50. BD Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 51. bioMrieux Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 52. Bio-Rad Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 53. DiaSorin Molecular Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 55. Luminex Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 56. Meridian Bioscience Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 57. OpGen Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 58. QIAGEN Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 59. Quidel Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 61. Trinity Biotech Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 62. Danaher Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed